Furthermore, we used an ELISA to quantitate the IgM and IgG antibody responses to rFliC in serum obtained from different groups of melioidosis patients (diabetes versus non-diabetes, bacteremia versus non-bacteremia and survivors versus non-survivors). This evidence concerns the gene CD40LG and diabetes mellitus.